UNSPSC 51332509: Fluanisone

This classification denotes an antipsychotic agent with the molecular formula C21H25FN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1D0W98U1I4, chemically known as 1-butanone, 1-(4-fluorophenyl)-4-(4-(2-methoxyphenyl)-1-piperazinyl)- (9ci) but generally known as fluanisone, which bears US NIH Compound Identifier 15139. European Medicines Agency schedules Fluanisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07662MIG.

UNSPSC 51332509 Fluanisone, a Commodity code, nominally refers to a specific pharmaceutical agent, but state and local governments are not currently soliciting this product. The recent activity tagged under the code reflects a mismatch: Seminole County, Florida posted an IFB for Naloxone and Safe Drug Deactivation Systems, which are distinct medical countermeasures unrelated to Fluanisone's pharmaceutical profile. The county's procurement addresses opioid overdose response and drug disposal, not the anesthetic properties Fluanisone provides. State and local purchasing offices appear to have applied this code incorrectly to a public health supply procurement, suggesting either miscoding in the source data or a cataloging error in the issuing body's system.

The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, calling for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors must include shipping and delivery costs, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation and commercial general liability insurance. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary termination clause. This code does not show active state and local procurement aligned with its nominal pharmaceutical scope; firms tracking this UNSPSC classification should monitor for recoding or verify whether Fluanisone is purchased at all under state and local vehicles before committing business development resources.